On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Joerg Herrmann

ResearcherPublications, citations & collaboration network

Joerg Herrmann is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Joerg Herrmann have?

ScholarIQindexed works

Joerg Herrmann has 366 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Joerg Herrmann have?

ScholarIQcitation count

Joerg Herrmann has 18,386 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Joerg Herrmann?

ScholarIQh-index

Joerg Herrmann has an h-index of 64 in OpenAlex.

What is the i10-index of Joerg Herrmann?

ScholarIQi10-index

Joerg Herrmann has an i10-index of 165 in OpenAlex.

What is the ORCID of Joerg Herrmann?

ScholarIQorcid

The ORCID for Joerg Herrmann is on the source record.

What is the OpenAlex record for Joerg Herrmann?

ScholarIQopenalex

The OpenAlex for Joerg Herrmann is on the source record.

What are the most-cited papers on Joerg Herrmann?

ScholarIQmost cited works
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, Riccardo Asteggiano, Marianne Aznar, Jutta Bergler‐Klein, Giuseppe Boriani, Daniela Cardinale, Raúl Córdoba, Bernard Cosyns, David J. Cutter, Evandro de Azambuja, Rudolf A. de Boer, Susan Dent, Dimitrios Farmakis, Sofie Gevaert, Diana A. Gorog, Joerg Herrmann, Daniel J. Lenihan, Javid J. Moslehi, Brenda Moura, Sonja S Salinger, Richard Stephens, Thomas Suter, Sebastian Szmit, Juan Tamargo, Paaladinesh Thavendiranathan, Carlo G. Tocchetti, Peter van der Meer, Helena J. H. van der Pal, ESC Scientific Document Group, Patrizio Lancellotti, Franck Thuny, Magdy Abdelhamid, Victor Aboyans, Berthe M.P. Aleman, Joachim Alexandre, Ana Barac, Michael A Borger, Rubén Casado-Arroyo, Jennifer Cautela, Jolanta Čelutkienė, Maja Čikeš, Alain Cohen‐Solal, Kreena Dhiman, Stéphane Éderhy, Thor Edvardsen, Laurent Fauchier, Michael G. Fradley, Julia Grapsa, Sigrun Halvorsen, Michael Heuser, Marc Humbert, Tiny Jaarsma, Thomas Kahan, Aleksandra Konradi, Konstantinos C Koskinas, Dipak Kotecha, Bonnie Ky, Ulf Landmesser, Basil S Lewis, Aleš Linhart, Gregory Y H Lip, Maja‐Lisa Løchen, Katarzyna Małaczyńska-Rajpold, Marco Metra, Richard Mindham, Marie Moonen, Tomas G. Neilan, Jens Cosedis Nielsen, Anna-Sonia Petronio, Eva Prescott, Amina Rakisheva, Joe‐Elie Salem, Gianluigi Savarese, Marta Sitges, Jurriën M. ten Berg, Rhian M. Touyz, Agnieszka Tycińska, Matthias Wilhelm, José Luis Zamorano, Nadia Laredj, Parounak Zelveian, Peter P. Rainer, Fuad Samadov, Uladzimir Andrushchuk, Bernhard Gerber, Mirsad Selimović, Elena Kinova, Jure Samardžić, Evagoras Economides, Radek Pudil, Kirsten M Nielsen, Tarek A Kafafy, Riina Vettus, Suvi Tuohinen, Stéphane Éderhy, Zurab Pagava, Tienush Rassaf, Αlexandros Briasoulis
European Heart Journal. 20222,870 CitationsOPEN ACCESS
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
Alexander R. Lyon, Susan Dent, Susannah Stanway, Helena Earl, Christine Brezden‐Masley, Alain Cohen‐Solal, Carlo G. Tocchetti, Javid J. Moslehi, John D. Groarke, Jutta Bergler‐Klein, Vincent Khoo, Li Ling Tan, Markus S. Anker, Stephan von Haehling, Christoph Maack, Radek Pudil, Ana Barac, Paaladinesh Thavendiranathan, Bonnie Ky, Tomas G. Neilan, Yu. N. Belenkov, Stuart D. Rosen, Zaza Iakobishvili, Aaron L. Sverdlov, Ludhmila Abrahão Hajjar, Ariane Vieira Scarlatelli Macedo, Charlotte Manisty, Fortunato Ciardiello, Dimitrios Farmakis, Rudolf A. de Boer, Hadi Skouri, Thomas Suter, Daniela Cardinale, Ronald Witteles, Michael G. Fradley, Joerg Herrmann, Robert F. Cornell, Ashutosh Wechelaker, Michael J. Mauro, Dragana Milojković, Hugues de Lavallade, Frank Ruschitzka, Andrew J.S. Coats, Petar Seferović, Ovidiu Chioncel, Thomas Thum, Johann Bauersachs, María Sol Andrés, David J. Wright, Teresa López‐Fernández, Chris Plummer, Daniel J. Lenihan
European Journal of Heart Failure. 2020796 CitationsOPEN ACCESS
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
Joerg Herrmann
Nature Reviews Cardiology. 2020731 CitationsOPEN ACCESS
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
Joerg Herrmann, Daniel J. Lenihan, Saro H. Armenian, Ana Barac, Anne Blaes, Daniela Cardinale, Joseph R. Carver, Susan Dent, Bonnie Ky, Alexander R. Lyon, Teresa López‐Fernández, Michael G. Fradley, Sarju Ganatra, Giuseppe Curigliano, Joshua D. Mitchell, Giorgio Minotti, Ninian N. Lang, Jennifer E. Liu, Tomas G. Neilan, Anju Nohria, Rupal O’Quinn, Iskra Pusic, Charles Porter, Kerry L. Reynolds, Kathryn J. Ruddy, Paaladinesh Thavendiranathan, Peter Valent
European Heart Journal. 2021624 CitationsOPEN ACCESS
5-fluorouracil and cardiotoxicity: a review
Jaskanwal Deep Singh Sara, Jasvinder Kaur, Ryan B. Khodadadi, Muneeb Rehman, Ronstan Lobo, Sakti Chakrabarti, Joerg Herrmann, Amir Lerman, Axel Grothey
Therapeutic Advances in Medical Oncology. 2018428 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial